Bristol-Myers Squibb names cancer expert as new board member

Bristol-Myers Squibb has announced the appointment of Dr Jose Baselga as a member of its board of directors and its science and technology committee.

Dr Baselga is the current physician-in-chief at the Memorial Sloan Kettering Cancer Center, one of the world's premier leading institutions, where he is responsible for the management of patient care and contributes to clinical and translational research projects.

He is also a professor of medicine at Weill Cornell Medical College, a position that reflects more than 30 years of clinical and research experience, including pioneering the development of treatments for women with HER2-positive breast cancer.

During his career, he has served as president of the American Association for Cancer Research, and has been in leadership roles for cancer research organisations such as the Breast International Group and the Ludwig Institute for Cancer Research.

Dr Giovanni Caforio, chairman and chief executive officer at Bristol-Myers Squibb, said: "Jose is an internationally-recognised physician scientist in oncology with deep experience in teaching at leading academic institutions, pioneering research for targeted cancer therapies and treating patients, which he still continues today."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.